share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/11/09 05:29

Moomoo AI 已提取核心信息

On November 7, 2024, HeartSciences Inc., also known as Heart Test Laboratories, held its Annual Meeting of Stockholders, where two key proposals were voted upon. The first proposal was the ratification of Haskell & White LLP as the company's independent registered public accounting firm for the fiscal year ending April 30, 2025. This proposal was approved with 413,499 votes for, 9,896 against, and 1,116 abstentions. The second proposal addressed the potential adjournment of the Annual Meeting to a later date if necessary to solicit additional proxies in the event of insufficient votes for any proposals. Shareholders approved this adjournment proposal with 367,736 votes for, 18,963 against, and 37,811 abstentions. No other issues were voted on at the meeting. The report was signed by Andrew Simpson, President, Chief Executive Officer, and Chairman of the Board of Directors, on November 8, 2024.
On November 7, 2024, HeartSciences Inc., also known as Heart Test Laboratories, held its Annual Meeting of Stockholders, where two key proposals were voted upon. The first proposal was the ratification of Haskell & White LLP as the company's independent registered public accounting firm for the fiscal year ending April 30, 2025. This proposal was approved with 413,499 votes for, 9,896 against, and 1,116 abstentions. The second proposal addressed the potential adjournment of the Annual Meeting to a later date if necessary to solicit additional proxies in the event of insufficient votes for any proposals. Shareholders approved this adjournment proposal with 367,736 votes for, 18,963 against, and 37,811 abstentions. No other issues were voted on at the meeting. The report was signed by Andrew Simpson, President, Chief Executive Officer, and Chairman of the Board of Directors, on November 8, 2024.
2024年11月7日,HeartSciences Inc.,也被称为Heart Test Laboratories,举行了其股东年度大会,对两项重要提案进行了表决。第一项提案是批准Haskell & White LLP为公司独立的注册会计师事务所,审计截至2025年4月30日的财政年度。该提案以413,499票赞成,9,896票反对和1,116票弃权获得批准。第二项提案涉及如有必要延期年度大会至稍后日期,以便在任何提案获得不足票数时征求更多委托。股东们通过了这个延期提案,以367,736票赞成,18,963票反对和37,811票弃权。会议上未提出其他问题。报告由董事会主席、首席执行官及总裁Andrew Simpson于2024年11月8日签署。
2024年11月7日,HeartSciences Inc.,也被称为Heart Test Laboratories,举行了其股东年度大会,对两项重要提案进行了表决。第一项提案是批准Haskell & White LLP为公司独立的注册会计师事务所,审计截至2025年4月30日的财政年度。该提案以413,499票赞成,9,896票反对和1,116票弃权获得批准。第二项提案涉及如有必要延期年度大会至稍后日期,以便在任何提案获得不足票数时征求更多委托。股东们通过了这个延期提案,以367,736票赞成,18,963票反对和37,811票弃权。会议上未提出其他问题。报告由董事会主席、首席执行官及总裁Andrew Simpson于2024年11月8日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息